Barclays PLC 10x Genomics, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Barclays PLC holds 602,536 shares of TXG stock, worth $9.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

602,536

Previous 602,536 -0.0%

Holding current value

$9.53 Million

Previous $13.6 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$15.71 - $23.49 $1.27 Million - $1.89 Million	80,579 Added 15.44%	602,536 $13.6 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $9.03 Million - $17.3 Million	464,221 Added 804.04%	521,957 $10.2 Million
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $7.52 Million - $11.3 Million	-208,562 Reduced 78.32%	57,736 $2.17 Million
Q4 2023 Feb 15, 2024	BUY	$34.32 - $57.55 $8.38 Million - $14 Million	244,099 Added 1099.59%	266,298 $14.9 Million
Q3 2023 Nov 07, 2023	BUY	$40.86 - $62.98 $23,862 - $36,780	584 Added 2.7%	22,199 $916,000
Q2 2023 Aug 03, 2023	BUY	$50.96 - $58.72 $508,071 - $585,438	9,970 Added 85.62%	21,615 $1.21 Million
Q1 2023 May 04, 2023	SELL	$35.33 - $55.79 $5.65 Million - $8.93 Million	-160,027 Reduced 93.22%	11,645 $649,000
Q4 2022 Feb 13, 2023	BUY	$24.4 - $41.3 $3.55 Million - $6.01 Million	145,505 Added 556.06%	171,672 $6.26 Million
Q3 2022 Nov 03, 2022	BUY	$28.48 - $52.59 $108,651 - $200,630	3,815 Added 17.07%	26,167 $745,000
Q2 2022 Aug 12, 2022	SELL	$36.95 - $82.41 $667,353 - $1.49 Million	-18,061 Reduced 44.69%	22,352 $1.01 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $2.25 Million - $5.89 Million	40,413 New	40,413 $3.07 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account